IFM Therapeutics

0 followers


At IFM Therapeutics, they work to improve the lives of patients with inflammatory disorders and cancer by developing transformative medicines that precisely target the innate immune system, the body’s first line of immunological response, and an essential component of immune function.

Industries

Employees

11-50

Links

Org chart

H. Martin Seidel
Chief Executive Officer

H. Martin Seidel

Collapse
Dennis Dean
Chief Development Officer
Ed Olhava
SVP of Preclinical Development
Ann Santilli
Executive Assistant Office Manager
Shankar Venkatraman
Executive Director
William R. Roush
EVP of Chemistry